Glycemie_2 - Optimization and implementation of a control system aiming the normalization of glycemia of critically ill patients
From 01-01-2008 to 31-12-2011
Description
Critically ill patients, typically admitted to the intensive care unit, show hyperglycemia and insulin resistance resulting in adverse outcomes. It has been previously shown that strict blood glucose control (between 80 and 110 mg/dl) results in an important reduction in mortality and morbidity. Current therapy requires a manual and rigorous administration of insulin and could, therefore, be replaced by a semi- or fully-automatic blood glucose control system leading to a potential decrease of the workload of the medical staff. In this project the basic predictive control system, that has recently been developed and that comprises a patient "model" and a "controller", will be refined. First of all, the prediction performance of the dynamic model will be increased (e.g., with the design of a more optimal adaptive algorithm for parameter estimation). Next, the performance of the existing controller will be improved (e.g., by implementing a moving horizon estimator). Moreover, the analysis of the glucose sensor measurement errors will be incorporated in the control system to further increase its efficiency. Finally, the designed control system will be validated in a real-life intensive care unit setting.Team
- Bart De Moor, Promoter
- Tom Van Herpe, Team member
Financing
Funding: FWO - Research Foundation - Flanders
Program/Grant Type: FWO Research Grant - FWO Research Grant
Events
2/09/2024:
PhD defense - Martijn Oldenhof
Machine Learning for Advanced Chemical Analysis and Structure Recognition in Drug Discovery
3/09/2024:
Meet the Jury Igor Tetko on Advanced Machine Learning in Drug Discovery
12/09/2024:
Multimodal analysis of cell-free DNA for sensitive cancer detection in low-coverage and low-sample settings
Seminar by Antoine Passemiers
News
STADIUS Alumni Herman Verrelst – new CEO of Biocartis
08 June 2017
Herman Verrelst, the founder of KU Leuven spin-off Cartagenia, who has been working in Silicon Valley, US for the last few years will be returning to Belgium to follow the steps of Rudi Pauwels as CEO of the Belgian diagnostic company, Biocartis.
Supporting healthcare policymaking via machine learning – batteries included!
29 May 2017
STADIUS takes the lead in the data analytics efforts in an ambitious European Project MIDAS.
Marc Claesen gives an interview about his PhD for the magazine of the Faculty of Engineering Sciences "Geniaal"
10 February 2017
Did you know that in Belgium approximately one third of type 2 diabetes patients are unaware of their condition?
Joos Vandewalle is nieuwe voorzitter KVAB
09 October 2016
Op 5 oktober 2016 heeft de Algemene Vergadering van de Academie KVAB Joos Vandewalle verkozen tot voorzitter van de KVAB.